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Background: With the clinical development of several antiviral intervention strategies for influenza, it becomes
crucial to explore viral load shedding in the nasal cavity as a biomarker for treatment success, but also to explore
sampling strategies for sensible and reliable virus collection.
Findings: In this study, 244 patients suffering from Influenza like Illness and/or acute respiratory tract infection were
enrolled. Sampling was done using mid-turbinate flocked swabs and two swabs per patient were collected (one
swab per nostril). The influenza A viral loads of two mid-turbinate flocked swabs (one for each nostril) per patient
were compared and we have also assessed whether normalization for human cellular DNA in the swabs could be
useful. The Influenza mid-turbinate nasal swab testing resulted in considerable sampling variability that could not
be normalized against co-isolated human cellular DNA.
Conclusions: Influenza viral load monitoring in nasal swabs could be very valuable as virological endpoints in
clinical trials to monitor treatment efficacy, in analogy to HIV, HBV & HCV viral load monitoring. However, the
differences between left and right nostrils, as observed in this study, highlight the importance of proper sampling
and the need for standardized sampling procedures.
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Respiratory tract infections (RTI) have an enormous so-
cial economic impact, with high incidence of hospitali-
zation and high costs [1,2]. Because of similar clinical
symptoms and simultaneous circulation of several dif-
ferent viruses, the etiology is often unknown. Timely de-
tection and discrimination of the infecting pathogens is
crucial to optimize treatment and care, to prevent un-
necessary antibiotic use, and to prevent secondary spread
of infection. Adequate specimen collection is the first cru-
cial step for the correct diagnosis of influenza and other
respiratory infections. Correction for the dilution in naso-
pharyngeal aspirates might improve the detection of re-
spiratory infections [3,4]. Many studies have described* Correspondence: lvwesenb@its.jnj.com
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article, unless otherwise stated.that mid-turbinate flocked swabs are less invasive than
other specimen collection types (nasopharyngeal swabs,
aspirates & washes), have a good sensitivity to detect
respiratory viruses and are therefore a good alternative
for specimen collection [5-11]. Moreover, these mid-
turbinate swabs have the possibility for self-collection
(either adult patients or parents of children at home)
[5-11]. To our knowledge, these studies have compared
the different specimen types and/or specimen collection
by a health care worker and self-collection, but none of
them have compared the variability of respiratory virus
detection between the two nostrils of the same patient at
the same time point. In HIV, HCV, and HBV, viral load
monitoring is a key diagnostic parameter to measure treat-
ment success [12-14]. With the clinical development of
several antiviral intervention strategies for influenza, it be-
comes crucial to explore viral load shedding in the nasal
cavity as a biomarker for treatment success, but also tod Central. This is an Open Access article distributed under the terms of the
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Figure 1 Variability plot of influenza A viral load or RnaseP
DNA as observed for two mid-turbinate swabs taken from
the same patient (n = 244). A: Influenza A viral load (r2=0.733):
One hundred samples have an InfA VL > LLOQ for both swabs
(r2 = 0.183). Dotted lines represent upper limit of quantification
(ULOQ) = 10.3 log10 copies/ml & lower limit of quantification
(LLOQ) = 4.3 log10 copies/ml. Viral load values below LLOQ are
plotted in the respective axes or on the origin. B: RnaseP DNA
(r2 = 0.242).
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collection. In this study, the influenza A viral loads of two
mid-turbinate flocked swabs (one for each nostril) per pa-
tient were compared. We have also assessed whether
normalization for human cellular DNA in the swabs could
be useful.
A total of 244 patients suffering from Influenza Like
Illness (ILI) and/or acute respiratory tract infection (RTI),
presenting for medical support at a primary care physi-
cians’ office in Belgium, were enrolled between February-
March 2012 and January-March 2013, as previously
described [15]. The study was approved by the Com-
mittee on Medical Ethics of the University Hospital of
Leuven in Belgium and written consent from all partici-
pants was obtained. Only patients symptomatic for
fewer than 3 days were included in the study. Sampling
was done using mid-turbinate flocked swabs (Copan,
Italy) and two swabs per patient were collected (one
swab per nostril; info on the order of the swab collec-
tions (left/right nostril) is not available). One swab was
re-suspended in 1 ml Universal transport medium (UTM)
(swab A) and the other swab in 3 ml UTM (swab B) to de-
fine if the swab collection in a smaller volume results in a
higher viral load. Swabs were kept refrigerated (4°C) until
transport to central lab where the samples were stored
at -80°C. Viral RNA was isolated using the Easymag sys-
tem (Biomerieux) and Influenza viral load was determined
in each swab using qRT-PCR, which was performed ac-
cording to our in-house protocol for Influenza A (InfA)
(targeting the Matrix gene) (based on the CDC protocol
[16]) with a panel of oligonucleotide primers and dual-
labeled hydrolysis (TaqMan®) probes, as previously de-
scribed [15]. Each sample was tested in duplicate. The
InfA qRT-PCR is characterized by a low inter- and intra-
variability (average %CV < 2.5%) (data not shown). All Ct
values were corrected for the loss of RNA during extrac-
tion by use of the internal extraction control (IEC) [17]. A
standard RNA dilution series (8 dilutions; External quanti-
fication control (EQC)) was tested in duplicate in each
qRT-PCR experiment [15]. The viral loads of the proc-
essed samples were calculated as log10 copies/ml through
back calculation on the EQC standard curve, which has
the following characteristics y = -3.03x + 40.17 with r2 =
0.99 and a linear range from 4.3 to 10.3 log10 copies/ml
(lower and upper limit of quantification (LLOQ and
ULOQ)). All samples with an InfA viral load below 4.3
log10 copies/ml were defined as ‘below LLOQ’. To detect
the amount of human cells in the mid-turbinate swabs,
qPCR (on DNA level) was performed with primers/probe
located on the human RNaseP gene, as proposed by CDC
[16]. Each sample was tested in duplicate. Amplification
and detection were performed on Lightcycler® 480 instru-
ment (Roche Applied Science). The 25 μl reaction mixture
of the qPCR was comprised of 5 μl of nucleic acid, 12.5 μlof 2x PCR master mix, 0.5 μl of Platinum® Taq Mix (Life
Technologies), 0.5 μl of forward and reverse primers
(40 μM) and 0.5 μl of labeled probe (10 μM), and 5.5 μl
water. The thermal cycling conditions were as follows:
95°C for 2 min, followed by 45 cycles of PCR amplifica-
tion (95°C for 15 s and 55°C for 30 s). A 1/10 dilution
series of human control genomic DNA (Applied Biosys-
tems) was tested in duplicate on each real-time PCR
plate and has the following characteristics: y = -3.33x +
40.04 with r2 = 0.99.
Two hundred forty four (244) patients were enrolled
in this study, resulting in a total of 488 swabs. Collection
of the swab in a smaller volume (Swab A) resulted in a
6.3 times higher InfA viral load compared to swab B. For
all subsequent analyses, the difference in volume was
mathematically corrected by adding 1.5 Ct to the ob-
tained Ct values of swab A. For 100 patients (41.0%), an
Figure 3 Correction of the influenza A viral load for amount of huma
A viral load of the swabs from both nostrils before and after correction for
and B InfA viral load (corrected for human cellular DNA) were classified into
relative frequency for each group were tabulated. (VL=viral load).
Figure 2 Plot of the RNaseP Ct values versus InfA log10 copies/ml
(n = 488; two swabs/patient) (r2 = 0,009 and slope = -0,06). Dotted
lines represent LLOQ & ULOQ of the InfA viral load assay.
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detected on both mid-turbinate swabs. One hundred
and twenty three patients (50.4%) had two swabs with an
InfA viral load below LLOQ. For 21 patients (8.6%) only
one swab was positive for InfA (the other swab was <
LLOQ for infA) (Figure 1A). The average InfA viral load
of swabs A & B of the 100 influenza A positive patients
was almost identical (6.86 log10 copies/ml for swab A
and 6.84 log10 copies/ml for swab B). In this subset of
samples (n = 100), a high variability of the infA viral load
between the left and right nostril was observed (r2 =
0.183). Eleven samples (out of the 100 concordant posi-
tive samples) had an InfA viral load difference of more
than 2 log10 copies/ml (Figure 1A). A wide range of hu-
man RNaseP DNA content was found in the 488 sam-
ples (range: 25.02 Ct - 38.51 Ct with an average of 31.76
Ct) (Figure 1B). A poor correlation between the RnaseP
Ct value of two swabs of the same patient was found
(r2 = 0.240). A very low amount of human DNA was found
in only 3 samples (Ct value of RNaseP >37), illustratingn cells in the swabs. A: Process flow. B: Comparison of the influenza
human cell content (n=100). Values < LLOQ are omitted. The Swab A
4 groups delimited by the first, second and third quartile and the
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ble amount of human DNA. As shown in Figure 2, the
RNaseP DNA content is independent of the influenza
A viral load. Indeed, InfA viral load between 5.06 &
6.73 log10 copies/ml was found in the 3 samples with a
low amount of human DNA (Ct value of RNaseP >37).
Figure 3A describes the process flow, which is per-
formed on the 100 concordant infA positive samples, to
correct the InfA viral load for the difference in cell con-
tent between the two swabs of a patient. The difference
between RNaseP Ct values of the two swabs of the
same patient was calculated. The log conversion of this
ΔCt value of RNAseP was added to the InfA viral load
of swab A. This corrected InfA viral load of swab A can
then be plotted against the viral load of swab B. As
shown in Figure 3B, only a slight improvement of the
correlation between both swabs of the same patient can
be observed (not corrected swab A (r2 = 0.183; mean of
difference = 0.02 ± 1.21) versus swab A corrected for
sampling (r2 = 0.286; mean of difference = 0.07 ± 1.15)).
To address the issue of the correlation varying across
the range of VL values, the Swab A and B InfA viral
load (corrected for human cellular DNA) were classi-
fied into 4 groups delimited by the first, second and
third quartile and the relative frequency for each group
were tabulated as an insert to Figure 3B.
Flu surveillance studies focus on identifying the circu-
lating influenza viruses and their main characteristics,
independent of the viral quantity. Influenza viral load
monitoring (on different timepoints) in nasal swabs
could be very valuable as virological endpoints in clini-
cal trials to monitor treatment efficacy, in analogy to HIV,
HBV & HCV viral load monitoring. The differences in
InfA viral load between the left and right nostrils, as
observed in this study, could be related to variability of
the qRT-PCR, biological differences between the nos-
trils, sampling bias or any combination of these. The
qRT-PCR is characterized by a low intra- and inter vari-
ability (CV < 2.5%). A right- or left-handed person may
obtain the swab differently from the right/left nostril or
the order of taking the swabs could also introduce vari-
ability. Unfortunately, that info was not collected in this
study but this should be included in further studies. The
biological differences could include anatomic nose/septum
abnormalities, variability in virus shedding or clogging of
the nostrils. The differences in Inf A viral load between left
and right nostrils, as observed in this study, highlight the
importance of proper sampling and the need for standard-
ized sampling procedures. Several options for sampling
can be proposed: one swab per patient (which is now the
case for most studies), two swabs per patient (one for each
nostril), two swabs per patient (one for each nostril) with
collection in the same vial, the use of one swab for sam-
pling of both nostrils. Further studies are definitely neededto further explore the use of mid-turbinate swabs, the
variability between the nostrils of a patient and to propose
one standard procedure for specimen collection which
would improve the adequate detection of influenza/
respiratory viruses and in the end will contribute to
adequately monitor treatment efficacy in clinical trials.
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